Completed PHASE4 INTERVENTIONAL 2-arm NCT02382354

Remifentanil for the I-gel and Laryngeal Mask Airway Insertion

Comparison of the Effect-site Concentration of Remifentanil for Insertion of the I-gel and Laryngeal Mask Airway During Propofol Anesthesia

Sponsor: Ajou University School of Medicine

Conditions Supraglottic Airways for General Anesthesia

Interventions i-gel laryngeal mask airway propofol remifentanil

Updated 6 times since 2017 Last updated: Oct 13, 2015 Started: Mar 31, 2015 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Supraglottic Airways for General Anesthesia and is currently completed. Ajou University School of Medicine leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajou University School of Medicine

Data source: Ajou University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suwon, South Korea